Eli Lilly's Retatrutide Advances in Weight Loss Drug Development | Retatrutide News

Eli Lilly is developing Retatrutide, a new weight loss drug, as part of its GLP-1 agonist pipeline. This development is significant for obesity treatmen...
Weight Loss · October 26, 2026